HALAVEN
Google image searchProduct monograph
Active ingredient
eribulin mesylate, 0.5 MG/ML
DIN: 02377438
Dosage form(s): SOLUTION
Route(s) of administration: INTRAVENOUS
Description: 2ML SINGLE USE VIAL
Schedule: Prescription
Company: EISAI LIMITED
Date: 19-MAR-2012
ATC:
- L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
- L01X — OTHER ANTINEOPLASTIC AGENTS (ATC, ATC/DDD)
- L01XX — Other antineoplastic agents (ATC, ATC/DDD)
- L01XX41 — ERIBULIN (ATC/DDD)
Reference brand drug: Halaven
